Spinocerebellar Ataxia Type 4
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 4

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia Type 4?
Spinocerebellar ataxia 4 (SCA4) is a very rare form of hereditary progressive movement disorder. Symptoms include muscle weakness (atrophy) and difficulty coordinating body movements (ataxia), most notably causing a jerky, unsteady walking style (gait) and difficulty speaking (dysarthria). A distinctive feature of SCA4 is the progressive loss of feeling or sensation in the hands and feet (peripheral neuropathy) and loss of reflexes. SCA4 is inherited in an autosomal dominant manner. Although SCA4 has been linked to a location on chromosome 16, (16q22.1), the gene which causes SCA4 when mutated has not been found. Diagnosis is based on symptoms consistent with the disease.
What are the alternative names for Spinocerebellar Ataxia Type 4?
  • Spinocerebellar ataxia 4
  • SCA4
  • Spinocerebellar ataxia autosomal dominant with sensory axonal neuropathy
  • Spinocerebellar ataxia type 4
Who are the top Spinocerebellar Ataxia Type 4 Local Doctors?
Distinguished in Spinocerebellar Ataxia Type 4
Family Medicine
Distinguished in Spinocerebellar Ataxia Type 4
Family Medicine

William M Handy, MD PC

389 Falls Dr NW, 
Abingdon, VA 
Languages Spoken:
English
Accepting New Patients

William Handy is a primary care provider, practicing in Family Medicine in Abingdon, Virginia. Dr. Handy is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 10, Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 15, and Spinocerebellar Ataxia Type 5. Dr. Handy is board certified in American Board Of Family Medicine. Dr. Handy is currently accepting new patients.

Elite in Spinocerebellar Ataxia Type 4
Elite in Spinocerebellar Ataxia Type 4
Referral may be required

Office

300 Medical Plz, 
Los Angeles, CA 
Languages Spoken:
English
Offers Telehealth

Susan Perlman is a Neurologist practicing medicine in Los Angeles, California. Dr. Perlman is rated as an Elite provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. She is also highly rated in 53 other conditions, according to our data. Her clinical expertise encompasses Spinocerebellar Ataxia, Friedreich Ataxia, Drug Induced Dyskinesia, and Olivopontocerebellar Atrophy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spinocerebellar Ataxia Type 4
Elite in Spinocerebellar Ataxia Type 4
Referral may be required
Otfried Müller Str. 23, 
Tuebingen, BW, DE 

Matthis Synofzik practices practicing medicine in Tuebingen, Germany. Mr. Synofzik is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 4. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Drug Induced Dyskinesia, Frontotemporal Dementia, Acute Cerebellar Ataxia, Spinocerebellar Ataxia, and Deep Brain Stimulation.

What are the latest Spinocerebellar Ataxia Type 4 Clinical Trials?
Clinical Research Consortium for the Study of Cerebellar Ataxias (CRC-SCA) for the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias (SCA)

Summary: Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of SCAs and this study will focus on types 1, 2, 3, 6, 7, 8, 10, 27B, and RFC1-ataxia (SCA 1, SCA 2, SCA 3, also known as Machado-Joseph disease, SCA 6, SCA 7, SCA 8, SCA 10, SCA27B, and RFC1-ataxia, also known as CANVAS). The diseases are rare...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center